Article Versions Notes

Tomiyoshi K, Wilson LJ, Mourtada F, Mourtada JS, Namiki Y, Kamata W, Yang DJ, Inoue T. Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology. Pharmaceutics. 2024; 16(11):1458. https://doi.org/10.3390/pharmaceutics16111458

Tomiyoshi, Katsumi, Lydia J. Wilson, Firas Mourtada, Jennifer Sims Mourtada, Yuta Namiki, Wataru Kamata, David J. Yang, and Tomio Inoue. 2024. "Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology" Pharmaceutics 16, no. 11: 1458. https://doi.org/10.3390/pharmaceutics16111458

Tomiyoshi, K., Wilson, L. J., Mourtada, F., Mourtada, J. S., Namiki, Y., Kamata, W., Yang, D. J., & Inoue, T. (2024). Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology. Pharmaceutics, 16(11), 1458. https://doi.org/10.3390/pharmaceutics16111458